STINGINN, LLC

Miami, FL · Biotech · Private

Novel vaccine to prevent and treat HTLV-1 associated diseases including Adult T cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: Miami, FL
Total capital: $5.8M

Federal grants: $5.8M; 8 awards · 2020–2024; Rank in peer group#121 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 4 pending · first 2024; Rank in peer group#142 of 514

Capital timeline

Latest events

Aug 2024Federal grantHealth and Human S · Phase II · Human T Cell Lymphotropic Virus Vaccine Development$1.0M
Aug 2023Federal grantHealth and Human S · Phase II · STING Activators as Therapy for Cancer$994K
Jul 2023Federal grantHealth and Human S · Phase I · Human specific STING agonists for the treatment of cancer$400K
Jan 2023Federal grantHealth and Human S · Phase I · Human T cell Lymphotropic Virus Vaccine development$288K
Sep 2022Federal grantHealth and Human S · Phase II · STING Activators as Therapy for Cancer$2M
Feb 2022Federal grantHealth and Human S · Phase I · Human T cell Lymphotropic Virus Vaccine development$588K
Dec 2021Federal grantHealth and Human S · Phase I · Anti-inflammatory Activity of a Systemic STING Inhibitory Non-Nucleotide$300K

Show 1 earlier federal award

Sep 2020Federal grantHealth and Human S · Phase I · STING Activators as Therapy for Cancer$252K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grants#121 · top 24%
Granted patents#142 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 6

Apr 14, 2026GrantedSubstituted 1,2,4-TRIAZOLES And Methods Of UseUSPTOUS 12,600,704
May 22, 2025PendingSubstituted 1,2,4-TRIAZOLES And Methods Of UseUSPTOApplication 18964388
Nov 5, 2024GrantedSubstituted 1,2,4-TRIAZOLES And Methods Of UseUSPTOUS 12,134,605

Show all 6 patent records

Substituted 1,2,4-TRIAZOLES And Methods Of UseApr 14, 2026 · US 12,600,704Granted
Substituted 1,2,4-TRIAZOLES And Methods Of UseMay 22, 2025 · Application 18964388Pending
Substituted 1,2,4-TRIAZOLES And Methods Of UseNov 5, 2024 · US 12,134,605Granted
Substituted 1,2, 4-TRIAZOLES And Methods Of UseApplication PCTUS2020065756Pending
Substituted 1,2,4-TRIAZOLES And Methods Of UseApplication 63126517Pending
Substituted 1,2,4-TRIAZOLES And Methods Of UseApplication 62949511Pending

Processa Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
IRIDIA, INC.Similar federal contract value in Biotech · null in contracts
Bluejay TherapeuticsSimilar federal contract value in Biotech · null in contracts
NOVICI BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts
AERIE PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
Gate BioscienceSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.